Evopoint Biosciences (also known as Suzhou Sinovent Pharmaceutical Technology, 苏州信诺维医药科技股份有限公司) is a company that researches and develops biopharmaceutical products. It offers beta (ß)-lactamase (BLI) inhibitors, EZH2 inhibitors, hURAT1 inhibitors, and antibody-drug conjugate (ADC), covering tumors, anti-infection, metabolism, and other diseases.